Brookfield Asset Management Ltd. (BAM)vsApplied DNA Sciences, Inc. (BNBX)
BAM
Brookfield Asset Management Ltd.
$48.05
-1.46%
FINANCIAL SERVICES · Cap: $74.11B
BNBX
Applied DNA Sciences, Inc.
$0.13
+48.11%
FINANCIAL SERVICES · Cap: $2.72M
Smart Verdict
WallStSmart Research — data-driven comparison
Brookfield Asset Management Ltd. generates 242292% more annual revenue ($5.07B vs $2.09M). BAM leads profitability with a 49.7% profit margin vs 0.0%. BAM appears more attractively valued with a PEG of 1.21. BAM earns a higher WallStSmart Score of 68/100 (B-).
BAM
Strong Buy68
out of 100
Grade: B-
BNBX
Hold48
out of 100
Grade: D+
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 33 in profit
Keeps 50 of every $100 in revenue as profit
Strong operational efficiency at 64.5%
Large-cap with strong market position
Revenue surging 23.8% year-over-year
Reasonable price relative to book value
Revenue surging 34.3% year-over-year
Areas to Watch
Moderate valuation
Trading at 10.1x book value
Grey zone — moderate risk
Weak financial health signals
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : BAM
The strongest argument for BAM centers on Return on Equity, Profit Margin, Operating Margin. Profitability is solid with margins at 49.7% and operating margin at 64.5%. Revenue growth of 23.8% demonstrates continued momentum.
Bull Case : BNBX
The strongest argument for BNBX centers on Price/Book, Revenue Growth. Revenue growth of 34.3% demonstrates continued momentum. PEG of 1.27 suggests the stock is reasonably priced for its growth.
Bear Case : BAM
The primary concerns for BAM are P/E Ratio, Price/Book, Altman Z-Score.
Bear Case : BNBX
The primary concerns for BNBX are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
BAM profiles as a growth stock while BNBX is a hypergrowth play — different risk/reward profiles.
BAM carries more volatility with a beta of 1.26 — expect wider price swings.
BNBX is growing revenue faster at 34.3% — sustainability is the question.
BAM generates stronger free cash flow (339M), providing more financial flexibility.
Bottom Line
BAM scores higher overall (68/100 vs 48/100), backed by strong 49.7% margins and 23.8% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Brookfield Asset Management Ltd.
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
Brookfield Asset Management is a leading global alternative asset manager and one of the largest investors in real assets.
Visit Website →Applied DNA Sciences, Inc.
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. The company is headquartered in Stony Brook, New York.
Compare with Other ASSET MANAGEMENT Stocks
Want to dig deeper into these stocks?